Consolidated Statements of Changes In Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Balance (in shares) at Dec. 31, 2021		17,995,344
Balance at Dec. 31, 2021	$ 56,569	$ 18	$ 114,724	$ (58,173)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		7,459
Exercise of stock options	151		151
Issuance of common stock in settlement of restricted and performance stock unites, net of shares withheld for employee taxes (in shares)		130,146
Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes	(2,450)		(2,450)
Stock-based compensation expense	4,043		4,043
Net change in unrealized loss on available-for-sale investments	(11)				(11)
Net loss	(15,142)			(15,142)
Balance (in shares) at Mar. 31, 2022		18,132,949
Balance at Mar. 31, 2022	$ 43,160	$ 18	116,468	(73,315)	(11)
Balance (in shares) at Dec. 31, 2022	19,668,603	19,668,603
Balance at Dec. 31, 2022	$ (15,181)	$ 20	125,406	(140,513)	(94)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	5,775	5,775
Exercise of stock options	$ 109		109
Issuance of common stock in settlement of restricted and performance stock unites, net of shares withheld for employee taxes (in shares)		110,729
Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes	(2,397)		(2,397)
Stock-based compensation expense	3,386		3,386
Net change in unrealized loss on available-for-sale investments	86				86
Net loss	$ (25,016)			(25,016)
Balance (in shares) at Mar. 31, 2023	19,785,107	19,785,107
Balance at Mar. 31, 2023	$ (39,013)	$ 20	$ 126,504	$ (165,529)	$ (8)